Q3 2021 Investor Relations Results slide image

Q3 2021 Investor Relations Results

Participants Company overview Pharmaceuticals Oncology Financial review Conclusion Appendix References Susanne Schaffert President, Novartis Oncology 32 Investor Relations | Q3 2021 Results 1 NOVARTIS | Reimagining Medicine
View entire presentation